title: Porcine theca cells produce immunoreactive beta-endorphin and change steroidogenesis in response to opioid agonist.
abstract: In earlier in vitro experiments opioids affected steroidogenesis in porcine luteal and granulosa cells. The present studies were undertaken to examine the effects of FK 33-824 (opioid agonist) alone or in combination with LH, PRL or naloxone (NAL, opioid antagonist) on steroidogenesis in cultured porcine theca cells. Moreover, we have tested beta-endorphin-like immunoreactivity (beta-END-LI) concentrations in culture media under control conditions and following treatments of theca cells with LH, PRL, progesterone (P4), oestradiol (E2) or testosterone (T). FK 33-824 and NAL significantly increased P4 release by theca cells and inhibited stimulatory effect of LH on this steroid output. PRL-induced P4 secretion from the cells was blunted only by FK 33-824. Secretion of androstenedione (A4) and T was essentially elevated in the presence of FK 33-824 and this potentiation of both androgen release was completely abolished by PRL. NAL blocked stimulatory effect of the opioid agonist only in case of T. Secretion of oestradiol and oestrone was completely free from the influence of both the opioid agonist and antagonist. Pig theca cells were able to produce beta-END-LI but none of tested hormones (LH, PRL, P4, E2 and T alone or in combination) significantly affected this production. In conclusion, these data indicate that porcine theca cells may produce beta-END-LI and change their steroidogenesis in response to opioid peptides.
authors.affiliation: Department of Animal Physiology, University of Warmia and Mazury in Olsztyn, 10-718 Olsztyn-Kortowo 5, Poland.
authors.forename: T
authors.initials: T
authors.lastname: Kamiński
authors.forename: S
authors.initials: S
authors.lastname: Okrasa
authors.forename: I
authors.initials: I
authors.lastname: Bogacka
authors.forename: G
authors.initials: G
authors.lastname: Siawrys
authors.forename: J
authors.initials: J
authors.lastname: Przała
mesh_terms: D000818:Animals; D005405:D-Ala(2),MePhe(4),Met(0)-ol-enkephalin / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005260:Female; D012739:Gonadal Steroid Hormones / Q000378:metabolism / Q000494:pharmacology; D006065:Gonadotropins, Pituitary / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D009294:Narcotics / Q000819:agonists*; D013552:Swine / Q000502:physiology*; D013799:Theca Cells / Q000187:drug effects / Q000378:metabolism*; D001615:beta-Endorphin / Q000096:biosynthesis* / Q000378:metabolism
chemical_list: D012739:Gonadal Steroid Hormones; D006065:Gonadotropins, Pituitary; D009292:Narcotic Antagonists; D009294:Narcotics; D009270:Naloxone; D001615:beta-Endorphin; D005405:D-Ala(2),MePhe(4),Met(0)-ol-enkephalin